Patents
Patents for C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
03/2003
03/06/2003WO2002099097A8 Novel compounds for chemiluminescense procedures
03/06/2003US20030045538 Viologen linked acridine based molecule and process for the preparation thereof
03/05/2003CN1400974A Amino acid derivatives and use thereof as NEP, ACE and ECE inhibitors
02/2003
02/13/2003US20030032801 Phenothiazine or iminodibenzyl derivatives as antimalarial agents
02/12/2003CN1397148A Luminescent element material and luminescent element comprising the same
02/11/2003CA2030715C Hexahydro-1h-quino¬4,3,2-ef|¬1,4|benzoxazepines and related compounds, a process and intermediates for their preparation and their use as medicaments
02/05/2003EP0934277B1 Process for the preparation of n- 2-(dimethylamino)ethyl]acridine-4-carboxamide
02/05/2003CN1100759C Xanthene and arcridine derivative and its use
02/04/2003US6514987 Useful for inactivating pathogens in a material, such as a blood product, and then degrades to breakdown products
01/2003
01/30/2003US20030023089 Compounds, compositions and methods for generating chemiluminescence with phosphatase enzymes
01/29/2003EP1278747A1 Pyrano, piperidino, and thiopyrano compounds and methods of use
01/28/2003US6512119 Bistable molecular mechanical devices with an appended rotor activated by an electric field for electronic switching, gating and memory applications
01/16/2003WO2003004091A2 Aromatic sulfenates for type i phototherapy
01/16/2003US20030013677 Anticancer agents
01/16/2003CA2452835A1 Aromatic sulfenates for type i phototherapy
01/15/2003EP1274404A1 Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents
01/15/2003EP0754178B1 Novel functionalized hydrophilic acridinium esters
01/15/2003CN1391469A Npyy5拮抗剂 Npyy5 antagonist
01/14/2003US6506517 Surface modified carbonaceous materials
01/14/2003CA2141494C Mediators suitable for the electrochemical regeneration of nadh, nadph or analogs thereof
01/08/2003EP1095011A4 Novel fluorescent lanthanide chelates
12/2002
12/17/2002US6495690 By reacting cyclic ketones with aliphatic aldehyde in presence of ammonia in gaseous phase in presence of catalyst
12/12/2002WO2002099428A1 Luciferin hydrazides
12/12/2002WO2002099424A2 Acridone derivatives as labels for fluorescence detection of target materials
12/12/2002WO2002099097A1 Novel compounds for chemiluminescense procedures
12/12/2002CA2754169A1 Acridone derivatives as labels for fluorescence detection of target materials
12/12/2002CA2448824A1 Novel compounds for chemiluminescense procedures
12/12/2002CA2448370A1 Luciferin hydrazides
12/11/2002EP1263733A2 Derivatives of quinoline as alpha-2 antagonists
12/10/2002US6492396 Substituted thioacetamides
12/05/2002US20020183512 Compounds for use in treatment of cancer
12/05/2002US20020183334 For therapy of sleepiness, promotion of wakefulness, treatment of Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, treatment of attention deficit hyperactivity disorder
12/05/2002US20020182581 Treating blood or blood products with compounds which have a mustard, aziridinium or aziridine group and a nucleic acid binding group
12/05/2002US20020179105 Reduced ignition propensity smoking article
11/2002
11/27/2002EP1259492A1 Substituted piperazine derivatives as mtp inhibitors
11/26/2002CA1341402C Chemiluminescent acridine derivatives and their use in luminescence immunoassays
11/21/2002US20020173651 By reacting cyclic ketones with aliphatic aldehyde in presence of ammonia in gaseous phase in presence of catalyst
11/20/2002EP1257538A2 9-alkylamino-1-nitroacridine derivatives
11/19/2002US6482943 Quinones as disease therapies
11/13/2002EP1255757A1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors
11/12/2002US6479504 Antagonism of immunostimulatory CpG-oligonucleotides by 4-aminoquinolines and other weak bases
11/12/2002US6479503 Cycloalkano-indole and -azaindole derivatives
10/2002
10/30/2002EP1252133A2 Pharmaceutical compounds
10/23/2002EP0778946B1 Novel method and kits for producing light from an acridan compound
10/16/2002EP1249233A1 Npyy5 antagonists
10/10/2002WO2002079191A1 Viologen linked acridine based molecule and process for the preparation thereof
10/10/2002WO2002079166A1 A process for the synthesis of an annulated pyridine base
10/10/2002US20020147209 Cycloalkano-indole and -azaindole derivatives
10/03/2002US20020143034 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
10/02/2002EP0679641B1 Sulfonamide and sulfonic ester derivatives each having tricyclic hetero ring
09/2002
09/26/2002US20020137784 Guanidine derivatives
09/19/2002US20020132821 Novel heteroaryl derivatives and their use as medicaments
09/19/2002US20020130317 Bistable molecular mechanical devices with an appended rotor activated by an electric field for electronic switching, gating and memory applications
09/19/2002US20020130316 A bistable molecule for a crossed-wire device comprising a pair of crossed wires that form a junction where one wire crosses another at an angle other than zero degrees and at least one connector species connecting said pair of crossed
09/06/2002WO2002067704A1 A reduced ignition propensity smoking article
09/04/2002EP0934278B1 Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumour agents
08/2002
08/29/2002WO2001012584A3 Pharmaceutical compounds
08/28/2002EP1234514A2 A reduced ignition propensity smoking article
08/28/2002EP1234186A1 Stabilizing a luminescent acridinium compound
08/22/2002WO2002064545A1 Acylated indanyl amines and their use as pharmaceuticals
08/15/2002US20020111491 Antitumor agents, topoisomerase inhibitors, notoxic
08/15/2002US20020111354 Novel heteroary1 derivatives and their use as medicaments
08/14/2002CN1089086C Luminide and macroluminide class of pharmaceuticals
08/01/2002WO2002059096A1 Processes and synthetic intermediates for preparing n-arylacridancarboxylic acid derivatives
08/01/2002WO2002008190A3 Novel heteroaryl derivatives and use thereof as anti-tumour agents
08/01/2002US20020103214 Novel heteroaryl derivatives and their use as medicaments
08/01/2002US20020102573 Monitoring, detecting, screening and determining pancreatic defects in humans; obtain and determine nucleotide sequence of sample, compare to control, detect mutation, evaluate human for pancreatic defects
08/01/2002US20020102380 Ionic compounds in which the anionic load has been delocalized; ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions including polymerization
07/2002
07/30/2002CA2056619C Method of inactivation of viral and bacterial blood contaminants
07/25/2002US20020099211 9-alkylamino-1-nitroacridine derivatives
07/24/2002EP1225169A1 Radiation-activated cytotoxin therapy
07/18/2002WO2002055503A1 Bistable tricyclic molecules with an appended rotor activated by an electric field for electronic switching, gating and memory applications
07/18/2002US20020094568 Apparatus for reducing concentration of low molecular weight compounds in biological composition
07/10/2002CN1358178A Pharmaceutical compounds
07/10/2002CN1357542A Fluorescent reagent 2-(N-acridone)-chlorethyl formate
07/09/2002US6417005 Covalently immobilized fluoroionophores as optical ion sensors
07/04/2002WO2002051942A1 Dyeing or printing of manufactured natural polymer and synthetic hydrophobic fibre materials
07/03/2002EP0915837B1 Glyoxylic acid derivatives
06/2002
06/25/2002US6410732 Processing and synthetic intermediates for preparing N-arylacridancarboxylic acid derivatives
06/25/2002US6410561 Analgesics
06/25/2002US6410219 Dectionn of pathogen deaction of pathogen by complexing
06/20/2002US20020076823 Near infrared chemiluminescent acridinium compounds and uses thereof
06/19/2002CN1354740A Pharmaceutical compounds
06/12/2002EP0907641B1 Fluoroionophores and their use in optical ion sensors
06/11/2002CA2222556C Adduct protection assay
06/04/2002US6399223 Compound for use in organic EL device and organic EL device
06/04/2002CA2029497C 4-acylaminopyridine derivative
06/04/2002CA2020667C 4-acyloxyquinoline derivatives and insecticidal or acaricidal compositions containing same
05/2002
05/30/2002WO2002043449A1 Luminescent element material and luminescent element comprising the same
05/28/2002US6395367 Electroconductivity
05/23/2002US20020061509 Detecting modulators of parathyroid hormone related peptide expression; obtain cells, transform with expression vectors, culture transformed cells, expose to modulator, monitor cell for adjustment gene expression
05/14/2002US6387547 Compound having naphthacene skeleton for use in organic electroluminescence device; produces light emission of satisfactory luminance, especially at long wavelength; improved light emitting performance lasts for long time
05/10/2002WO2002036568A1 N-type calcium channel antagonists for the treatment of pain
05/09/2002US20020055644 Xanthone analogs for treating infectious diseases and complexation of heme and porphyrins
05/09/2002US20020055635 Cycloalkano-indole and -azaindole derivatives
05/08/2002EP1203091A1 Chemiluminescent substrates of hydrolytic enzymes such as phosphatases
05/08/2002EP1119554A4 Xanthan-ester and acridan substrates for horseradish peroxidase
05/02/2002US20020052512 Diaminopropionic acid derivatives
05/02/2002EP1201650A2 Ionic malonitril derivatives and their uses
05/02/2002DE10051628A1 Mittel zur Inaktivierung von pathogenen Keimen und dessen Verwendung Means for inactivation of pathogenic microorganisms and the use thereof
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 ... 22